PKI vs RIGL
PKI (PKI) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
PKI (PKI) common stock.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
PKI does not have a complete income-statement cache yet.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the PKI and RIGL stock pages for the full models.
Not investment advice.